ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery
- PMID: 39313728
- PMCID: PMC11549143
- DOI: 10.1245/s10434-024-16266-w
ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery
References
-
- Pitsinis V, Kanitkar R, Vinci A, Choong WL, Benson JR. The results of a prospective randomised multicentre study comparing indocyanine green (ICG) fluorescence combined with a standard tracer versus ICG alone for sentinel lymph node biopsy in early breast cancer: the INFLUENCE trial. Ann Surg Oncol. 2024. 10.1245/s10434-024-16176-x. - PMC - PubMed
-
- Pitsinis V, Provenzano E, Kaklamanis L, Wishart GC, Benson JR. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer. Surg Oncol. 2015;24(4) - PubMed
-
- Pitsinis V, Brown D, Elseedawy E, Vinci A, Macaskill J. Indocyanine green as an alternative to radioisotope in breast cancer sentinel node biopsy: a single center experience during COVID19. Eur J Surg Oncol. 2021;47(2) - PubMed
-
- Ng S, Pitsinis V, Elseedawy EH, Brown D, Vinci A, Jones BA, Macaskill EJ. Indocyanine green is a safe and effective alternative to radioisotope in breast cancer sentinel lymph node biopsy regardless of patient body mass index. Eur Surg Res. 2023;64(2):230–6. - PubMed
LinkOut - more resources
Full Text Sources
